Apotex Adds New Patent Challenge In Boniva Dispute
Stepping up its efforts to win approval for a generic form of Hoffmann-La Roche Inc.'s osteoporosis drug Boniva, Canadian drugmaker Apotex Inc. has challenged the validity of one of Roche's patents....To view the full article, register now.
Already a subscriber? Click here to view full article